JAYANT NATH
Glaxo Group – Appellant
Versus
United Biotech – Respondent
Jayant Nath, J.
1. The present suit is filed by the plaintiff seeking a decree of permanent injunction to restrain the defendant from manufacturing, selling, offering for sale, advertising, etc. the medicinal products or other related goods under the trade mark ‘HEPROTEC’ or any mark deceptively similar to the plaintiffs’ trade mark ‘HEPITEC’ and for other connected reliefs.
2. IA No.13265/2011 is an application filed under Order 39 Rules 1 and 2 CPC by the plaintiff seeking interim injunction to restrain the defendant etc. from manufacturing, selling, offering for sale or dealing in medicinal products or other related products under the trade mark ‘HEPROTEC’ or any mark deceptively similar to the plaintiffs’ trade mark ‘HEPITEC’.
3. The matter came up for hearing on 23.08.2011 when this court passed ex parte injunction restraining the defendant, its directors, principals, officers, agents, employees and representatives from manufacturing, selling and advertising directly or indirectly medicinal products under the trade mark ‘HEPROTEC’. The defendant has now filed IA No. 14230/2011 under Order 39 Rule 4 CPC for vacation of the stay. The two applications IA No.13265/2011 and
Ruston & Hornsby Ltd. vs. The Zamindara Engineering Co.
Cadila Health Care Ltd. vs. Cadila Pharmaceuticals Ltd.
Kaviraj Pandit Durga Dutt Sharma vs. Navaratna Pharmaceutical Laboratories
Bihar Tubes Ltd v. Garg Ispat Ltd. 166 (2010) DLT 109
Parle Products (P) Ltd v. J.P. and Co.
Cadila HealthCare Ltd. vs. Cadila Pharmaceuticals Ltd.
Sh.Swaran Singh Traders vs. M/s.Usha Industries (India) 29(1986) DLT 110.)
Login now and unlock free premium legal research
Login to SupremeToday AI and access free legal analysis, AI highlights, and smart tools.
Login
now!
India’s Legal research and Law Firm App, Download now!
Copyright © 2023 Vikas Info Solution Pvt Ltd. All Rights Reserved.